Pharmacological analysis of the novel, selective α1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand

57Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

1. Pharmacological profiles of tritiated KMD-3213, a new antagonist of α1-adrenoceptor (AR), were examined in recombinant and native α1-AR, and compared with those of prazosin (PZ) and tamsulosin (YM-617). 2. In saturation experiments, [3H]-KMD (10-2000 pM) showed high affinity for α(1a)-AR (pK(D) = 10.5). However, no significant binding to α(1b)-AR and insufficient/unsaturated binding to α(1d)-AR were observed at concentrations up to 2000 pM. In contrast, [3H]-PZ and [3H]-YM bound to all subtypes with high affinity (pK(D) > 9). In competition experiments, KMD-3213 also had higher affinity for α(1a)-AR than for other two subtypes; pK(i)= 10.4, 8.1 and 8.6 for α(1a)-, α(1b)- and α(1d)-AR, respectively. 3. [3H]-KMD also bound to the native α(1A)-AR (rat submaxillary gland) with high affinity, but not to α(1β)-AR (rat liver). In rat kidney which expresses α(1A)- and α(1B)-AR, [3H]-KMD and [3H]-PZ bound to a single high-affinity site (pK(D) = 10.8 and 10.1, respectively) with distinct amount of binding sites (B(max) = 159 and 267 fmol mg-1 protein, respectively). [3H]-PZ binding sites consisted of low- and high-affinity sites for KMD-3213 (pK(i) = 7.6 and 10.7, respectively), for WB4101 (pK(i) = 8.1 and 10.0) and for YM-617 (pK(i) = 8.7 and 10.8). The proportion of the high affinity site was approximately 60% in these drugs which was compatible to the ratio between B(max) of [3H]-KMD and [3H]-PZ. [3H]-KMD binding sites consisted of a single site for these drugs with affinities which were similar to these of the high affinity sites in [3H]-PZ binding. 4. In functional experiments, KMD-3213 antagonized the contractile responses to NS-49 or noradrenaline (NA) with higher affinity in functional α(1A)- (rat caudal artery, pA2 = 10.0 against NS-49) and α(1L)-AR (dog mesenteric artery, pA2 = 9.9 against NA) than in α(1B)- (dog carotid artery, pA2 = 7.7 against NA) and α(1D)-AR (rat thoracic aorta, pA2 = 8.3 against NA). 5. These results confirm the α(1A)-AR selectivity and high affinity of KMD-3213, and indicate that[3H]-KMD can label selectively α(1A)-AR.

Cite

CITATION STYLE

APA

Murata, S., Taniguchi, T., & Muramatsu, I. (1999). Pharmacological analysis of the novel, selective α1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand. British Journal of Pharmacology, 127(1), 19–26. https://doi.org/10.1038/sj.bjp.0702489

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free